Stability of Ertapenem in an Elastomeric Infusion Device
Author(s): Phipps Stephen D, Peacock Gina F, Smith Douglas L
Issue: May/Jun 2011 - Volume 15, Number 3
View All Articles in Issue
Page(s): 252-254
Download in electronic PDF format for $75
Abstract: Ertapenem is an intravenous antibiotic that is dosed once daily and is utilized in the home infusion setting for parenteral antibiotic therapy. Thepurpose of this study was to evaluate the stability of ertapenem in an elastomeric infusion device over a one-week period. A stability-indicating high-performance liquid chromatographic method for ertapenem was identified from the literature and evaluated in our laboratory. Under our experimental conditions, the method demonstrated acceptable precision (1.8% relative standard deviation) and linearity (r2 = 0.998). Five 1-g vials of commercial grade ertapenem were reconstituted with 10 mL of sterile water for injection according to the manufacturer’s directions and then transferred into an elastomeric infusion device along with 90 mL of 0.9% sodium chloride solution (concentration of 10 mg/mL). After preparation of the ertapenem solutions, the five elastomeric infusion devices were stored under refrigerated conditions (5oC). Ertapenem concentrations were assayed in duplicate at the time of initial preparation and at subsequent 24-hour intervals throughout the study. Ertapenem concentrations were quantified by interpolation from a standard curve; ertapenem standard curves were generated each day of the study from solutions of known ertapenem concentration that were prepared from ertapenem analytical standard. At the 72-hour time point, ertapenem concentrations from each of the five elastomeric infusion pumps remained greater than 90% of initial concentration. At the 120-hour time point, the overall average ertapenem concentration was 90.4% of initial concentration, but two out of the five concentrations were below 90% of initial concentration. At the end of the 7-day study, the overall average ertapenem concentration was 88.9% of initial concentration and only one concentration was greater than 90% of initial concentration. Based on the results from this study, a beyond-use date of 3 days (72 hours) is conservatively recommended for ertapenem solutions prepared in Homepump ECLIPSE elastomeric infusion devices that are stored under refrigerated conditions.
Related Keywords:
Stephen D. Phipps, PharmD, PhD, Gina F. Peacock, PhD, Douglas L. Smith, PharmD, BCNSP, BCOP, ertapenem, antibiotic, stability, intravenous administration, home infusion, elastomeric infusion device, storage conditions
Related Categories:
INFUSION, PARENTERALS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, INFECTIOUS DISEASE, STORAGE
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Stability of Ertapenem in an Elastomeric Infusion Device
Phipps Stephen D, Peacock Gina F, Smith Douglas L
|
May/Jun 2011
Pg. 252-254
|
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
|
Sep/Oct 2015
Pg. 432-436
|
Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device
Tsiouris Maria, Ulmer Marisa, Yurcho James F, Hooper Kevin L, Gui Min
|
Sep/Oct 2010
Pg. 436-439
|
Disposable Ambulatory Infusion Devices: A Review - Part 3
Ashworth Lisa D
|
Nov/Dec 2000
Pg. 442-443
|
Home Infusion Basics for the Non-Infusion Pharmacist
Miron Karen E
|
Mar/Apr 2011
Pg. 94-100
|
Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump
Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
|
Jul/Aug 2016
Pg. 343-346
|
Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve, Williams LaVonn A
|
May/Jun 2011
Pg. 183-188
|
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
|
Jul/Aug 2000
Pg. 281-285
|
Ambulatory Syringe Infusion Devices: A Review - Part 2
Ashworth Lisa D
|
Sep/Oct 2000
Pg. 364
|
Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping, Trissel Lawrence A
|
May/Jun 2002
Pg. 226-229
|
Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags
Kaiser Jeanette, Kramer Irene
|
Nov/Dec 2011
Pg. 515-520
|
Home Infusion 101
Williams LaVonn A
|
Jan/Feb 2011
Pg. 6-10
|
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags
Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M
|
Sep/Oct 2017
Pg. 436-439
|
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018
Pg. 345-349
|
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
|
Mar/Apr 2002
Pg. 152-154
|
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016
Pg. 148-154
|
Home Infusion: Overview of the Infusion Patient-Care Process
Kennedy Steve
|
Jul/Aug 2011
Pg. 270-276
|
Comparison of Three Reconstitution Devices: A Simulated Time and Use Study
Penoyer Daleen, Giuliano Karen, Middleton Aurea
|
Mar/Apr 2023
Pg. 169-174
|
Home Infusion: Overcoming the Barriers to Entry
Franklin David M
|
Nov/Dec 2010
Pg. 450-455
|
Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration
Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
|
Nov/Dec 2007
Pg. 520-524
|
Return to Top |